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A molecule called hemoglobin is found in red blood cells that holds oxygen all over the body. 
Hemoglobin is elastic, round, and stable in a healthy human. This makes it possible to float across 
red blood cells. But the composition of hemoglobin is unhealthy if you have sickle cell disease. It 
refers to compact and bent red blood cells. The odd cells obstruct the flow of blood. It is dangerous 
and can result in severe discomfort, organ damage, heart strokes, and other symptoms. The human 
life expectancy can be shortened as well. The early identification of sickle calls will help people 
recognize signs that can assist antibiotics, supplements, blood transfusion, pain-relieving 
medications, and treatments etc. The manual assessment, diagnosis, and cell count are time 
consuming process and may result in misclassification and count since millions of red blood cells 
are in one spell. When utilizing data mining techniques such as the multilayer perceptron classifier 
algorithm, sickle cells can be effectively detected with high precision in the human body. The 
proposed approach tackles the limitations of manual research by implementing a powerful and 
efficient MLP (Multi-Layer Perceptron) classification algorithm that distinguishes Sickle Cell 
Anemia (SCA) into three classes: Normal (N), Sickle Cells(S) and Thalassemia (T) in red blood 
cells. This paper also presents the precision degree of the MLP classifier algorithm with other 
popular mining and machine learning algorithms on the dataset obtained from the Thalassemia 
and Sickle Cell Society (TSCS) located in Rajendra Nagar, Hyderabad, Telangana, India. 
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Natural blood passes in a tiny circular form that brings oxygen to organs from parts of the human body that are 
spherical and have a lifespan of around 120 days which produces a new blood cell every 120 days [1]. Sickle cell anemia 
is a particular form of irregular blood disorder that causes natural hemoglobin in the red blood cells to change its shape. 
Sickle cell form is Sticky and hard Disc form, which allows the blood supply to cease in the human body [2]. The 
average cycle of sickle cells is 10 to 20 days. Because of the involvement of sickle cells [3] in hemoglobin, it may cause 
extreme episodes of discomfort, tissue loss, and serious complications, in some cases leading to death [4]. 
In above Figure 1, it is clear indicated that the usual blood flow carries oxygen through all areas of the blood without 
slowing, where the sickle cell form becomes sticky and the blood flow ceases [5] at some point. Since the blood flow 
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ceases, it may cause serious body pains and heart strokes etc. Sickle cell was found in the black community and was 
later seen in citizens of many ethnic groups, including citizens from parts of the Middle East, Central India, the 
Mediterranean Region, Italy, and Greece in particular [6]. Treatment for Sickle Cell Disease by taking early drugs such 
as Antibiotics, Blood Transfusion, Bone Marrow. For at least 1-2 months, most physicians prescribe blood transfusion, 
and patients can take antibiotics to treat risks, including persistent pain. SCD is an uncommon blood condition [7] in the 
human body that is now found in the hemoglobin of newborn babies. SCD is a crescent-shaped cell that is stiff, sticky, 
and associates with other cells. If one organ is gradually damaged it can spread across the body, which may contribute 
to death. To escape this kind of illness, early treatment is needed to stop severe problems (Blood Transfusion). A person 
develops hemoglobin S, which is triggered by two defective genes. 
    
 
Figure 1. Blood Flow of Sickle Cells. 
1-1- Syndromes and Indications of Sickle Cell Anemia [8] 
Signs of sickle cell anemia and symptoms typically begin at the age of 5 months. They differ and alter with time 
from individual to individual. Symptoms and signs can involve: 
1) Episodes of pain: The RBC prevents blood supply into narrow blood vessels joints, abdomen, and lungs which 
is one of the main signs of sickle cells. Chronic discomfort has been identified in bones, ulcers, and joint injuries 
in adults and teenagers. 
2) Distressing swelling of hands and feet: RBC inhibits the blood supply of hands and feet because of the sickle 
cell involvement in the body and may swell in the hands and feet. 
3) Frequent infections: Due to cellular sickle damage in bodies that trigger organ harm (infection fights i.e.   
spleen). Physicians also prescribe vaccinations and drugs to avoid diseases that endanger patient health, such as 
pneumonia. 
3) Disrupted development: If RBCs in the human body are decreased by a lack of oxygen, which can contribute 
to slower development. 
4) Vision problems: RBC prevents sickle cell blood flow through tiny blood vessels. Such cells do not supply the 
eyes with oxygen, which may contribute to retinal injury. It creates trouble with the vision. 
1-2- Sickle Cell Complications [9] 
1) Heart Stroke: Cardiac stroke may arise when the blood supply to the brain is disrupted by the sickle cells. The 
stroke signs include arms and legs fatigue or numbness, frequent speech difficulties, lack of consciousness [10]. 
2) Acute chest syndrome: It induces thorn discomfort, fever, and breathing trouble. The issue, which can also lead 
to life-threats, is very severe. Clinical intervention is needed with the usage of antibiotics and other therapies 
[11]. 
3) Pulmonary Hypertension: High blood pressure in the lungs (pulmonary hypertension) can occur in patients 
with sickle cell anemia. This condition affects not only the children but also adults. Symptoms can trigger 
breathing difficulties and tiredness. 
4) Leg Ulcers: SCA (sickle cell anemia) can cause open sores, where ulcers on the legs can develop. 
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5) Gallstones. A substance such as bilirubin may be produced by the RBC breakdown. If bilirubin has a high body 
level that contributes to gallstones. 
1-3- Statistical Information [12] 
In Indian Scenario [12] 
1) First portrayed in northern Tamil Nadu in 1952 in the Nilgiri Hills. 
2) The sickle cell gene is now considered to be common among citizens in central India's Deccan plateau with less 
emphasis in northern Kerala and Tamil Nadu. 
In worldwide Scenario [12] 
1) Sickle cells were originally unknown, but now spread across the world and are found particularly in the Western 
Hemisphere (Caribbean, South America, and Central America), Saudi Arabia, Asia, and the Mediterranean 
countries (Greece, ITA, Turkey), Sub-Saharan Africa[13]. 
2) In the African-American countries, sickle cell death is more observed; between 1999 and 2002, sickle cell 
mortality [14] in children younger than 4 years declined by 42%. The reduced sickle cell in 2000, which defends 
against infectious diseases of the pneumococcal community, was detected through vaccination. 
3) Sickle cell disease was reported in California, Illinois, and New York during the period 1990-1994 by the 
newborn screening of mortality infants. 
4) In Africa-American children with SCD in California and Illinois, mortality rates stood at 1.5 per 100 by the end 
of 1995. African / American or black babies born in California and Illinois have a mortality rate of 2.0 per 100 
Blacks or African-Americans during this time [15]. 
5) SCD is one of the biggest public health issues, with the total expense of around $475 million for Hospitalization 
related to SCD in the US of 75000. 
The rest of this paper is presented as follows: A comprehensive review of the sickle cell crisis and various attempts 
to find the crises through computational methods is described in section-2 (Literature Review). Complete overview of 
the dataset used in this experimentation is mentioned in section-3. Section-4 includes the previous results obtained on 
the dataset and usage of Multi-Layer Perceptron that escalates the prediction accuracy. Section-5 presents the results 
obtained from Multi-Layer Perceptron and the results comparison with other models can be found.  
2- Literature Review 
2-1- Sickle Cell Disease-A Comprehensive Study and Usage of Technology for Diagnosis [16] 
A comprehensive study of sickle cell disease with the properties, symptoms, signs, and treatment procedure is 
mentioned. The authors also present the comprehensive study and characteristics of the disease with other similar 
diseases (like thalassemia) along with technological implications and usage in the field of sickle cell disease. 
2-2- Healthy and Unhealthy Red Blood Cell Detection in Human Blood Smears using Neural Networks [17] 
The following methods are used in this paper for diagnosing anemia: A hemoglobin level recognition system, focused 
on a microscopic blood smear examination, and an RBC classification. The author used neural networks to classify and 
count [18] three forms of anemia (Sickle cells, elliptocytosis cells, microsite cells, and cells with unknown shapes) by 
utilizing circular Hough transformations and morphological tools in a microscope. 
2-3- Emerging Point-of-care Technologies for Sickle Cell Disease Diagnostics [19] 
In this paper, POC platforms are developed to ensure cost efficiency and portability which enables millions of people 
in low-resource countries to be diagnosed with sickle cell anemia as potentially improbable. A comprehensive literature 
analysis was conducted to evaluate the sensitivity and specification of several POC diagnostics produced for SCD with 
an emphasis on resource constraint use. In this paper, Microfluidic paper-based devices, Paper-based tests for screening 
newborns, Sickle cell detection using a smartphone etc. are discussed. 
2-4- Data Mining Technique using WEKA Classification for Sickle Cell Disease [17] 
In this paper, two classification strategies, J48 and Random Tree are used, to forecast cell disease, heavily affected 
in Gujarat tribal regions, and then contrasted J48 and Random Tree categorization strategies for the mining method. The 
author contrasted this strategy to the Random Tree. For this prediction method, the WEKA platform is used as an open-
source application. 
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2-5- A Comparative Analysis by KNN, SVM & ELM Classification to Detect Sickle Cell Anemia [8] 
In this paper, the dataset of blood samples is taken in picture format. In the image pre-processing phase, gray 
photography, noise filters, and image enhancement are transformed. This paper also presents Fuzzy C which classifies 
regular and sickle cells. For analysis, the graphical and mathematical properties are used. The author used KNN, SVM, 
and Extreme Learning Machine classification tools [20] to evaluate images [21]. 
2-6- Edge Detection of Sickle Cells in Red Blood Cells [4] 
In this paper, the sickle and the regular cells are identified by measuring the smaller, largest, and medium radius of 
each cell by contrasting that with the typical cell dimension. For this method, sickle cells with red circles are labelled 
using edge detection techniques [22]. Regular, sickle, and other irregular cells are located using a microscope in the 
clinical process, but manually it is impossible to identify superimposed cells. In this automatic process, blood cells 
overlapped and incomplete are first observed, and then separated to regular or irregular cells by means of specific edge 
finding algorithms depending on the shape of each cell derived from a microscopic picture [23]. 
2-7- Automatic Blood Cell Segmentation using K-Mean Clustering from Microscopic Thin Blood Images [25] 
In this source, Savkare [25] presents an automatic blood cell segmentation in parasitic diseases using K-Means 
algorithms on online image library (http://www.dpd.cdc.gov/dpdx/ and is tested on 60 microscopic thin blood images 
with an accuracy of 98.89% for clustering.  
2-8- Machine Learning Approaches to the Application of Disease Modifying Therapy for Sickle Cell using 
Classification Models [26] 
Khalaf [26] has obtained the results with several algorithms on sickle cell disease especially using Elman-Jordan 
Hybrid Neural Network (EJNN) and Levenberg Marquardt algorithm (LEVNN) where the accuracy is very higher than 
other models. 
2-9- Detection of Anemia Disease in Human Red Blood Cells using Cell Signature, Neural Networks and SVM [22] 
Elsalamony et al. has done the detection of sickle cell anemia disease in RBC using various popular 
algorithms like cell signature, Support Vector Machine (SVM), Back Propagation (BP) and Self-Organizing 
Map (SOM) neural networks by testing with 45 microscopic colour images from 15 patients who is already 
suffering with this kind of anemia. 
3- About Dataset 
As part of this project [A collaborative Research project awarded by Jawaharlal Nehru Technological University, 
Hyderabad, TEQIP-III (funding agency) for Rs.3,00,000/-, we had executed a Memorandum of Understanding (MoU) 
between our Institute named Vallurupalli Nageswara Rao Vignana Jyothi Institute of Engineering & Technology, 
Bachupally, Hyderabad, Telangana, India 500 090 (VNRVJIET) and Thalassemia and Sickle Cell Society, Rajendra 
Nagar, Hyderabad, Telangana, India (TSCS) (MoU dated 15 Oct 2019). The details of TSCS is accessible from 
https://www.tscsindia.org/. 
The MoU aimed with the following objectives: 
● Data Sharing and 
● Technology Transfer 
We have received a dataset of 1387 records of patients who have approached TSCS for the diagnosis purpose. These 
records are shared to us as part of MoU and the records are pre-processed to maintain confidentiality, anonymity that 
meets data privacy of patients. This data of the patients gathered during August 2017 to August 2019. 
 After pre-processing, 13 attributes are identified along with the class label (Diagnosis of a Blood sample). The 
complete list of attributes, their meaning and can be found from our previous research article (in press) presented at 
ICACECS-2020 (International Conference on Advances in Computer Engineering and Communication Systems 2020) 
and available in Gowtham et al. (2020) [27]. 
4- Implementation 
In Gowtham et al. (2020) [27] study, we have presented the results of prediction of identification of Thalassemia and 
Sickle Cell traits in the blood samples using the classification algorithms [28] is summarized [27] in Table 1: 
 
Emerging Science Journal | Vol. 5, No. 2 
Page | 204 
Table 1. Comparison study of results of various classification algorithms. 
S. No. Name of the Classification Algorithm 
Result of prediction 
accuracy (%) 
Dataset Size (No of observations 
X No of Parameters) 
1 Support Vector Machine (SVM) 76.00 1387 X 13 
2 K-Nearest Neighbor Algorithm (KNN) 77.00 1387 X 13 
3 Logistic Regression (L) 78.00 1387 X 13 
4 Decision Tree Classifier (DTC) 95.00 1387 X 13 
5 Random Forest Algorithm (RF) 96.00 1387 X 13 
Later, another 100 records of patients were received who approached TSCS (during the period September 2019 to 
August 2020) that could help us to experiment and test with another model called “Multi-Layer Perceptron (MLP) 
Classifier”. 
The aim of this work is the production and identification of sickle cell anemia with the aid of Multilayer Perceptron. 
The model architecture includes three stages, such as Dataset preparation, Analyzing dataset, splitting dataset (Training 
and Testing), and usage of classification algorithms [29]. The proposed classifier, named Multi-Layer Perceptron 
Classifier gives the detection results on the sickle cell anemia. The implementation of the proposed technique in 
PYTHON. The system is evaluated in terms of Accuracy and Log Loss to show the performance of the technique. 
4-1- Dataset Preparation 
As stated above, 1387 patients with 13 parameters are included in the data collection obtained from Thalassemia and 
the Sickle Cell Society. The parameters are explained in Table 2.    
Table 2. The 13 parameters present in the dataset with an explanation. 
S. No. Parameter Name Description 
1 AGE The period that person has lived 
2 Hemoglobin (HB) A red protein responsible for transporting Oxygen in the blood of vertebrates. 
3 Hematocrit (HCT) The ratio of the volume of red blood cells to the total volume of blood 
4 RBC Distribution Width (RDW) 
It is a measure of the range of variation of red blood cell volume that is reported as part of a 
standard complete blood count 
5 Mean Corpuscular Volume (MCV) It is a measure of the average volume of a blood corpuscle. 
6 Mean Corpuscular Hemoglobin (MCH) It is the average mass of hemoglobin per red blood cell in a sample of blood. 
7 
Mean Corpuscular Hemoglobin 
Concentration (MCHC) 
It is a measure of the concentration of hemoglobin in each volume of packed red blood cells. 
8 Red Blood Cell (RBC) The blood cells that carry oxygen 
9 Reticulocytes (RETIC) 
An immature red blood cell without a nucleus, having a granular or reticulated appearance 
when suitably stained. 
10 Fetal Hemoglobin (HBF) It is the main oxygen carrier protein in the human fetus. 
11 HBA0 It is defined as the non-glycated hemoglobin. 
12 HBA2 
It is a normal variant of hemoglobin A that consists of two alpha and two delta chains and are 
found at low levels in normal human blood 
13 Diagnosis 
Diagnosis is the output variable; We need to predict based on a set of features(inputs) wither 
it is a Normal Cell / Sickle Cell / Thalassemia Cell 
4-2- Analyzing Dataset and Splitting Dataset 
Every patient's details (i.e. diagnosis) with AS, AT, BT, EA, EE, ET, NN, SC, SS, ST, TM, TT, have been named by 
thalassemia society. The 12 diagnosis names are translated into three major classes as mentioned below  
1) NN                                              = N (Normal Cells) 
2) AS, SC, SS, ST                          = S (Sickle Cells) 
3) AT, BT, EA, EE, ET, TM, TT = T (Thalassemia Cells) 
Usually datasets are dealt-in machine learning that have multiple labels in one or more columns. The training data is 
also labelled in words to render it comprehensible or understandable in human terms. 
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Label Encoding involves transforming labels into numeric types to make them readable by the computer.  Machine 
learning algorithms will then help to determine how to run the labels. For the organized data set in supervised learning, 
it is an essential pre-processing phase. 
The dataset is split using a train-test-split function which is helpful to partition the data into a training set and test set 
(of 80% and 20 % respectively) provided by scikit-learn. The training set includes a known value, and the model learns 
from that data such that other data can later be generalized. The reference dataset (or subclass) to check the accuracy of 
our model for this subclass is available. 
4-3- Multi-Layer Perceptron (MLP) Classifier 
MLP Classifier is often called a perceptron classifier of multilayer representation [30] that indicates a neural network 
itself. To conduct the classification process, MLP Classifier depends on an elementary Neural Network. That is ANN 
(Artificial Neural Network). The expression MLP is used ineffectively, often almost for every forward ANN, and often 
specifically refers to multi-layer perceptron networks (with threshold activation). Now and then, multilayer perceptrons 
are called "vanilla" neural networks, particularly if they involve one secret layer. It is rather robust and can usually be 
used to know the mapping from input to output. The lab findings are long-term avoidance. 
MLPs are valuable in analysis to solve problems stochastically, also offering estimated answers for highly 
complicated problems like an approximation of fitness. MLPs allow effective classification of algorithms as a special 
case of regressions, where the answer variable is categorical. In the 1980s, MLPs became common for machine learning 
approaches, and they found implementations in a variety of different fields, such as speech recognition, Image-
recognition, and machine translation tools. Because of the achievements of deep learning, curiosity in history contact 
networks resurfaced. 
 
Figure 2. Architecture of the proposed network model for MLP classification. 
As shown in the above figure-2, the proposed model of MLP comprises four layers of non-linearly triggering nodes 
(an input and an output layer of two hidden layers). Since MLPs are completely connected, each node in one-layer binds 
to each node in the corresponding layer, with a certain weight. 
Training happens in the perceptron after analyzing each piece of data by adjusting relation weights, depending on 
the magnitude of the performance error compared with the expected result. It is an example of controlled learning and 
a generalization of the lowest mean square technique in linear vision by backpropagation. 
MLP Classifier trains iteratively because the partial loss function derivatives are computed for updating the 
parameters in conjunction with model parameters in any step. It may also be applied to the loss function with a 
regularization time that reduces configuration parameters to avoid overfitting [31, 32]. 
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Figure 3. Confusion Matrix of MLP Classifier. 
5- Results  
The classifier is implemented in PYTHON 3.6 with the configuration of the PC that has a processor Intel I7 running 
on Windows 10 OS with 16 GB RAM. The system suggested in this paper is measured based on confusion matrix, which 
includes Accuracy score, precision, recall, f1-score. Metrics assessment techniques [24] are defined as below fig-4: 
 
Furthermore, a confusion matrix is a table that reports the counts of true positive, false positive, true negatives and 
false negatives which are defined as: 
 True Positive (TP): The label belongs to the class, and it is correctly predicted; 
 False Positive (FP): The label does not belong to the class, but classifier predicted as positive; 
 True Negative (TN): The label does not belong to the class, and it is correctly predicted; 
 False Negative (FN): The label does not belong to the class, but is predicted as negative; 
Figure 4. Metrics assessment techniques. 
The following formulae is used in arriving the various measures of accuracy. 
𝐴𝑐𝑐𝑢𝑟𝑎𝑐𝑦 =
𝑇𝑃 + 𝑇𝑁










𝐹 − 𝑀𝑒𝑎𝑠𝑢𝑟𝑒 =
2 × 𝑅𝑒𝑐𝑎𝑙𝑙 × 𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛
𝑅𝑒𝑐𝑎𝑙𝑙 +  𝑃𝑟𝑒𝑐𝑖𝑠𝑖𝑜𝑛
 (4) 
And finally, the results obtained using all classification algorithms including the MLP is shown in the following 
Table 3. 
Confusion Matrix: 
[[95 0 3] 
[1 39 0] 
[6 1 133]] 
Accuracy Score: 0.960431654676259 
Report: 
  Precision recall f1-Score Support 
 0 0.93  0.97 0.95  98 
 1 0.97  0.97 0.97  40 
 2 0.98  0.95 0.96  140 
Accuracy    0.96  278 
Macro avg 0.96  0.96 0.96  278 
Weighted avg 0.96  0.96 0.96  278 
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Table 3. Comparison study of various classification algorithms over the dataset including MLP classifier. 
S. No. Name of the Classification Algorithm 
Result of prediction 
accuracy (%) 
Dataset Size (No of observations X 
No of Parameters) 
1 Support Vector Machine (SVM) 76.00 1387 X 13 
2 K-Nearest Neighbor Algorithm (KNN) 77.00 1387 X 13 
3 Logistic Regression (L) 78.00 1387 X 13 
4 Decision Tree Classifier (DTC) 95.00 1387 X 13 
5 Random Forest Algorithm (RF) 96.00 1387 X 13 
6 MLP Classifier 96.04 1387 X 13 
Validation of results: Sincere thanks to TSCS for providing an additional dataset of 100 patients records (data of 
patients approached to TSCS during September 2019 to August 2020) is selected for validation of the performance of 
the algorithms and is expressed as follows mentioned in Table 4. 
Table 4. Validation results on dataset by various classification algorithms. 
S. No. Name of the Classification Algorithm 
Result of prediction 
accuracy (%) 
Dataset Size (No of observations X 
No of Parameters) 
1 Support Vector Machine (SVM) 80.00 100 X 12 
2 K-Nearest Neighbor Algorithm (KNN) 83.00 100 X 12 
3 Logistic Regression (L) 82.00 100 X 12 
4 Decision Tree Classifier (DTC) 95.00 100 X 12 
5 Random Forest Algorithm (RF) 97.00 100 X 12 
6 MLP Classifier 99.00 100 X 12 
5-1- Web Application Development 
A web application is developed based on the inputs given by TSCS especially that uses popular machine learning 
algorithms. The results are demonstrated to the team at TSCS using the Google Meet service. The team at TSCS has 
expressed their satisfaction and happiness about the performance of the application. The application is ready to deploy 
at the premises of TSCS for their regular usage. 
6- Conclusion 
Sickle cell anemia is a hematological condition, it was historically one of the peculiar traits of the indigenous 
community, but now it extends to the entire world and requires emergency treatment. This paper describes Sickle Cell 
Disease (SCD) and its history both internationally and in the national scenario (in the Indian context). The disease 
symptoms, signs, complications, and treatment are presented. Blood cells have also been characterized by different 
blood criteria among people with sickle-cell and Thalassemia patients. This paper further describes sickle cell disease 
with better precision with Multi-Layer Perceptron and builds an effective predictive model to minimize time and actions 
of sickle cell disease pain control systems. This paper examines the working model of the deep-learning model called 
“MLP Classifier” that gives efficient results than the other models like Support Vector Machine, K-Nearest Neighbor, 
Logistic Regression, Decision Tree Classifier and Random Forest Algorithms. The results of the simulations 
demonstrate that the proposed MLP classification has a 99 percent accuracy of prediction for both sickle cell and 
thalassemia. A web application is also developed for usage in the TSCS environment that includes the prediction model 
with the MLP classification algorithm even by a normal medical laboratory staff in an easier and simpler way. 
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